Advancing Research International. LLC (01090)

Clinical research site in Indianapolis, Indiana

As of July 2026, 1 paid clinical trial is recruiting at Advancing Research International. LLC (01090) in Indianapolis, Indiana. Active studies at this site focus on Geographic Atrophy Secondary to Age-related Macular Degeneration alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Advancing Research International. LLC (01090) (1)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for Geographic Atrophy Secondary to Age-related Macular Degeneration

78 locations incl. Gilbert

Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All·Age: 60+

Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

More research sites in Indianapolis

Indiana University (100 trials)
Riley Hospital for Children (67 trials)
Indiana University School of Medicine (54 trials)
Indiana University/Melvin and Bren Simon Cancer Center (33 trials)
Indiana University Melvin and Bren Simon Comprehensive Cancer Center (27 trials)
Indiana University Health (22 trials)
Indiana University Health University Hospital (20 trials)
Saint Catherine Hospital (20 trials)
Community Health Network (19 trials)
Indiana University Hospital (17 trials)

Explore more

Paid clinical trials in Indianapolis, IN · Indiana clinical trials